Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models

被引:0
|
作者
Xu Steven Xu
Adrian Dunne
Holly Kimko
Partha Nandy
An Vermeulen
机构
[1] Johnson & Johnson Pharmaceutical R&D,Clinical Pharmacology, Advanced PK
[2] Janssen Research & Development,PD Modeling and Simulation
[3] University College Dublin,Clinical Pharmacology, Advanced PK
关键词
Pharmacokinetics; Parameter estimate; BQL;
D O I
暂无
中图分类号
学科分类号
摘要
The objectives of the simulation study were to evaluate the impact of BQL data on pharmacokinetic (PK) parameter estimates when the incidence of BQL data is low (e.g. ≤10%), and to compare the performance of commonly used modeling methods for handling BQL data such as data exclusion (M1) and likelihood-based method (M3). Simulations were performed by adapting the method of a recent publication by Ahn et al. (J Phamacokinet Pharmacodyn 35(4):401–421, 2008). The BQL data in the terminal elimination phase were created at frequencies of 1, 2.5, 5, 7.5, and 10% based on a one- and a two-compartment model. The impact of BQL data on model parameter estimates was evaluated based on bias and imprecision. The simulations demonstrated that for the one-compartment model, the impact of ignoring the low percentages of BQL data (≤10%) in the elimination phase was minimal. For the two-compartment model, when the BQL incidence was less than 5%, omission of the BQL data generally did not inflate the bias in the fixed-effect parameters, whereas more pronounced bias in the estimates of inter-individual variability (IIV) was observed. The BQL data in the elimination phase had the greatest impact on the volume of distribution estimate of the peripheral compartment of the two-compartment model. The M3 method generally provided better parameter estimates for both PK models than the M1 method. However, the advantages of the M3 over the M1 method varied depending on different BQL censoring levels, PK models and parameters. As the BQL percentages decreased, the relative gain of the M3 method based on more complex likelihood approaches diminished when compared to the M1 method. Therefore, it is important to balance the trade-off between model complexity and relative gain in model improvement when the incidence of BQL data is low. Understanding the model structure and the distribution of BQL data (percentage and location of BQL data) allows selection of an appropriate and effective modeling approach for handling low percentages of BQL data.
引用
收藏
页码:423 / 432
页数:9
相关论文
共 50 条
  • [41] A Bayesian approach for estimating hexabromocyclododecane (HBCD) diastereomer compositions in water using data below limit of quantification
    Ichihara, Makiko
    Yamamoto, Atsushi
    Kakutani, Naoya
    Sudo, Miki
    Takakura, Koh-ichi
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2017, 24 (03) : 2667 - 2674
  • [42] The present and future of withdrawal period calculations for milk in the European Union: dealing with data below the limit of quantification
    Henri, J.
    Jacques, A-M.
    Sanders, P.
    Chevance, A.
    Laurentie, M.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2017, 40 (02) : 116 - 122
  • [43] A Bayesian approach for estimating hexabromocyclododecane (HBCD) diastereomer compositions in water using data below limit of quantification
    Makiko Ichihara
    Atsushi Yamamoto
    Naoya Kakutani
    Miki Sudo
    Koh-ichi Takakura
    Environmental Science and Pollution Research, 2017, 24 : 2667 - 2674
  • [44] Impact estimates for static spatial panel data models in R
    Piras, Gianfranco
    LETTERS IN SPATIAL AND RESOURCE SCIENCE, 2014, 7 (03): : 213 - 223
  • [45] Analysis of toxicokinetic data using NONMEM: Impact of quantification limit and replacement strategies for censored data
    Hing, JP
    Woolfrey, SG
    Greenslade, D
    Wright, PMC
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2001, 28 (05) : 465 - 479
  • [46] Analysis of Toxicokinetic Data Using NONMEM: Impact of Quantification Limit and Replacement Strategies for Censored Data
    Jeremy P. Hing
    Steven G. Woolfrey
    Dennis Greenslade
    Peter M. C. Wright
    Journal of Pharmacokinetics and Pharmacodynamics, 2001, 28 : 465 - 479
  • [48] Bayesian Fisher Information Matrix for Predicting Estimation Error and Shrinkage of Individual Parameters with Data Below the Quantification Limit
    Thi Huyen Tram Nguyen
    Thu Thuy Nguyen
    Mentre, France
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S41 - S41
  • [49] Impact of measurement error and limited data frequency on parameter estimation and uncertainty quantification
    Zadeh, Farkhondeh Khorashadi
    Nossent, Jiri
    Woldegiorgis, Befekadu Taddesse
    Bauwens, Willy
    van Griensven, Ann
    ENVIRONMENTAL MODELLING & SOFTWARE, 2019, 118 : 35 - 47
  • [50] ANALYSIS OF PHARMACOKINETIC DATA USING PARAMETRIC MODELS .2. POINT ESTIMATES OF AN INDIVIDUALS PARAMETERS
    SHEINER, LB
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1985, 13 (05): : 515 - 540